GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Other Current Receivables

Neurogene (Neurogene) Other Current Receivables : $0.59 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Other Current Receivables?

Neurogene's Other Current Receivables for the quarter that ended in Mar. 2024 was $0.59 Mil.

Neurogene's quarterly Other Current Receivables increased from Sep. 2023 ($0.58 Mil) to Dec. 2023 ($0.60 Mil) but then stayed the same from Dec. 2023 ($0.60 Mil) to Mar. 2024 ($0.59 Mil).

Neurogene's annual Other Current Receivables increased from Dec. 2021 ($0.79 Mil) to Dec. 2022 ($0.99 Mil) but then declined from Dec. 2022 ($0.99 Mil) to Dec. 2023 ($0.60 Mil).


Neurogene Other Current Receivables Historical Data

The historical data trend for Neurogene's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Other Current Receivables Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
Other Current Receivables
0.79 0.99 0.60

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial - 0.58 0.58 0.60 0.59

Neurogene Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Neurogene Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Neurogene's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurogene (Neurogene) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines